Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study

scientific article published on 19 October 2015

Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1050225699
P356DOI10.1245/S10434-015-4914-4
P698PubMed publication ID26480848

P50authorDiane GoereQ40350292
Thierry AndréQ56250413
Olivier GlehenQ57655409
P2093author name stringDominique Elias
Simon Msika
Jean-Marc Gornet
Clarisse Eveno
Marc Pocard
Guillaume Passot
Nelson Lourenco
Jean-Marc Sabaté
Jerome Lambert
BIG-RENAPE Working Group
Marianne Maillet
P2860cites workPerioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialQ24647888
Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal originQ33777576
Estimates of cancer incidence and mortality in Europe in 2008.Q34095813
Peritonectomy proceduresQ34316366
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trialsQ34597234
Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08Q34662825
Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis.Q38199370
Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French studyQ39928697
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialQ42677492
Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis.Q46621721
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.Q53286355
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trialQ57207899
P433issue3
P921main subjectperitoneal carcinomatosisQ2071182
multicenter clinical trialQ6934595
colon cancerQ18555025
P304page(s)863-869
P577publication date2015-10-19
P1433published inAnnals of Surgical OncologyQ2853069
P1476titleEarly Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study
P478volume23

Reverse relations

cites work (P2860)
Q41612691Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives.
Q41547533Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence
Q39864102Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Q91676659Perceptions in the management of colorectal peritoneal metastases: A bi-national survey of colorectal surgeons
Q64087322Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, r
Q28067123Therapeutic options for peritoneal metastasis arising from colorectal cancer
Q38787018Treatment of peritoneal metastases from small bowel adenocarcinoma

Search more.